72 related articles for article (PubMed ID: 29010665)
1. A Case of Arsenical Dermatitis Following Injections of Novarsenobillon.
Bannerji BP
Ind Med Gaz; 1927 Feb; 62(2):81. PubMed ID: 29010665
[No Abstract] [Full Text] [Related]
2. TWO FATAL CASES OF ICTERUS GRAVIS FOLLOWING INJECTIONS OF NOVARSENOBILLON.
Fenwick PC; Sweet GB; Lowe EC
Br Med J; 1918 Apr; 1(2990):448-50. PubMed ID: 20769006
[No Abstract] [Full Text] [Related]
3. SEVERE DERMATITIS DURING TREATMENT WITH NOVARSENOBILLON.
Leonard LG
Br Med J; 1919 Dec; 2(3076):773-4. PubMed ID: 20769732
[No Abstract] [Full Text] [Related]
4. A CASE OF RAT-BITE FEVER TREATED SUCCESSFULLY BY INJECTIONS OF NOVARSENOBILLON.
Low GC; Cockin RP
Br Med J; 1918 Feb; 1(2981):203-4. PubMed ID: 20768940
[No Abstract] [Full Text] [Related]
5. Syphilitic Rash first appearing after Twenty-three Injections of Novarsenobillon.
Bunch JL
Proc R Soc Med; 1918; 11(Dermatol Sect):78-80. PubMed ID: 19979998
[No Abstract] [Full Text] [Related]
6. Cases of (1) Arsenical Jaundice, (2) Arsenical Dermatitis, showing the Results of a Special Treatment.
Chamberlain F
Proc R Soc Med; 1922; 15(Dermatol Sect):26-7. PubMed ID: 19982233
[No Abstract] [Full Text] [Related]
7. Contact sensitivity to arsenical compounds. Clinical and experimental studies.
Wahlberg JE; Boman A
Derm Beruf Umwelt; 1986; 34(1):10-2. PubMed ID: 2937622
[TBL] [Abstract][Full Text] [Related]
8. Unusual Case of Arsenical Dermatitis.
Cambell A
Proc R Soc Med; 1933 Jun; 26(8):996-7. PubMed ID: 19989386
[No Abstract] [Full Text] [Related]
9. Arsenical Pigmentation of Unusual Extent and Severity in a Case of Pruriginous Dermatitis of the Besnier Type.
Semon H
Proc R Soc Med; 1932 Feb; 25(4):385. PubMed ID: 19988504
[No Abstract] [Full Text] [Related]
10. Case of Arsenical Dermatitis with Multiple Epitheliomata.
Barber HW
Proc R Soc Med; 1925; 18(Dermatol Sect):14-5. PubMed ID: 19984257
[No Abstract] [Full Text] [Related]
11. Case of Arsenical Dermatitis with Granulomatous Nodules.
Gray AM
Proc R Soc Med; 1924; 17(Dermatol Sect):9-10. PubMed ID: 19983626
[No Abstract] [Full Text] [Related]
12. On the Incidence of Arsenical Dermatitis.
Chakravarty HK
Ind Med Gaz; 1933 Jul; 68(7):383-385. PubMed ID: 29009452
[No Abstract] [Full Text] [Related]
13. Arsenical Dermatitis after "606".
Harnett WL
Ind Med Gaz; 1921 Dec; 56(12):441-443. PubMed ID: 29007198
[No Abstract] [Full Text] [Related]
14. Biological and behavioral factors modify biomarkers of arsenic exposure in a U.S. population.
Calderon RL; Hudgens EE; Carty C; He B; Le XC; Rogers J; Thomas DJ
Environ Res; 2013 Oct; 126():134-44. PubMed ID: 23777639
[TBL] [Abstract][Full Text] [Related]
15. Defective beta1-integrins expression in arsenical keratosis and arsenic-treated cultured human keratinocytes.
Lee CH; Chen JS; Sun YL; Liao WT; Zheng YW; Chai CZ; Chen GS; Yu HS
J Cutan Pathol; 2006 Feb; 33(2):129-38. PubMed ID: 16420308
[TBL] [Abstract][Full Text] [Related]
16. Novarsenobillon and Mapharside in the Treatment of the Attack of Malaria.
Treu R
Ind Med Gaz; 1944 Jun; 79(6):294. PubMed ID: 29012101
[No Abstract] [Full Text] [Related]
17. Novarsenobillon and Mapharside in the Treatment of the Attack of Malaria.
Lowe J
Ind Med Gaz; 1944 Mar; 79(3):97-99. PubMed ID: 29012006
[No Abstract] [Full Text] [Related]
18. The Price of Novarsenobillon.
May And Baker Limited
Ind Med Gaz; 1928 May; 63(5):294. PubMed ID: 29011686
[No Abstract] [Full Text] [Related]
19. Notes on Two Cases of Encephalitis Hæmorrhagica after Novarsenobillon Administration.
Sen K
Ind Med Gaz; 1925 Jul; 60(7):323-324. PubMed ID: 29010204
[No Abstract] [Full Text] [Related]
20. Notes on Novarsenobillon.
Bose RM
Ind Med Gaz; 1920 Sep; 55(9):334-335. PubMed ID: 29008533
[No Abstract] [Full Text] [Related]
[Next] [New Search]
